Mar 30, 2026

Featuring perspectives from Prof Karim Fizazi and Dr Daniel George, moderated by Dr Elisabeth I Heath, including the following topics:

• Introduction (0:00)
• Clinical Implications of and Appropriate Strategies to Identify PTEN Deficiency in Prostate Cancer — Dr George (3:25)
• Targeting AKT in Metastatic Prostate Cancer...

Feb 10, 2026

Featuring patient case presentations by Dr Fern Anari and Dr Catherine Fahey, with commentary from Dr Matthew D Galsky, including the following topics:

• EMBARK trial: Enzalutamide for biochemically recurrent prostate cancer (0:00)
• Final results from the Phase III PRESTO study: Combined androgen blockade for high-risk...

Jan 29, 2026

Featuring patient case presentations by Dr Fern Anari and Dr Catherine Fahey, with commentary from Dr Matthew D Galsky, including the following topics:

• AKT inhibitors for PTEN-deficient de novo metastatic hormone-sensitive prostate cancer (0:00)
• Radioligand-directed therapy for PSMA-positive...

Jan 23, 2026

Featuring patient case presentations by Dr Fern Anari and Dr Catherine Fahey, with commentary from Dr Matthew D Galsky, including the following topics:

• Case: A man in his early 60s with metastatic urothelial bladder cancer (mUBC) and medical history of tobacco use receives first-line enfortumab vedotin (EV) and...

Dec 19, 2025

Featuring perspectives from Dr Terence Friedlander and Dr Rana R McKay, including the following topics:

• Introduction (0:00)
• Prostate Cancer (1:44)
• Urothelial Bladder Cancer (29:18)

CME information and select...